Mark Thomson is a Biotechnology Commercial Leader with extensive experience in the pharmaceutical industry. They served as Vice President of Marketing at Epizyme from 2020 to 2022 and held various positions at Johnson & Johnson, including Regional Business Director for Gastroenterology and several roles in oncology and immunology. Currently, Mark is the VP and Global Commercial Lead for IBD & TL1a at Sanofi, having also been the Global Lead for New Product Planning in GI and Rheumatology there. They earned an MBA in Marketing from UNC Kenan-Flagler Business School and a B.S. in Biology and Economics from Bates College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices